MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 1, 2008; DOI: 10.1124/mol.108.049031


0026-895X/09/7503-637-647$20.00
Mol Pharmacol 75:637-647, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.108.049031v1
75/3/637    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orcel, H.
Right arrow Articles by Rabié, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orcel, H.
Right arrow Articles by Rabié, A.

Differential Coupling of the Vasopressin V1b Receptor through Compartmentalization within the Plasma MembraneFormula

Hélène Orcel, Laura Albizu, Sanja Perkovska, Thierry Durroux, Christiane Mendre, Hervé Ansanay, Bernard Mouillac, and Alain Rabié

Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, Montpellier, France and Institut National de la Santé et de la Recherche Médicale, U661, Montpellier, France and Université Montpellier, 1, 2, Montpellier, France (H.O., L.A., S.P., T.D., C.M., B.M., A.R.); and Cisbio Bioassays, Bagnols-sur-Cèze, France (H.A.)

We show here that the rat vasopressin V1b receptor simultaneously activates both the Gq/11-inositol phosphate (IP) and Gs-cAMP pathways when transiently expressed in Chinese hamster ovary, human embryonic kidney (HEK) 293, and COS-7 cells and stimulated with arginine-vasopressin. Higher concentrations of the hormone, however, were needed to trigger the cAMP pathway. The nonmammalian analog arginine-vasotocin and the selective V1b agonist d[Cha4]vasopressin also activated the cAMP and IP pathways, although d[Cha4]-vasopressin elicited the two responses with equivalent potencies. We determined that the V1b receptor is present as a homodimer at the plasma membrane. Treatment of V1b-transfected HEK-293 cells with methyl-β-cyclodextrin, a drug known to dissociate cholesterol-rich domains of the plasma membrane, shifted the EC50 of the vasopressin-induced cAMP accumulation to lower concentrations and, remarkably, increased the hormone efficacy related to the activation of this second messenger system. In parallel, the vasopressin-mediated activation of the IP pathway was slightly reduced without modification of its EC50. These results suggest that, as with many other G protein-coupled receptors, when transfected in heterologous cell systems, the V1b receptor forms dimers that signal differentially through the Gq/11 and Gs proteins depending on the nature of the ligand as well as on its localization within specialized compartments of the plasma membrane. The present study thus illustrates how signal transduction associated with the activation of a G protein-coupled receptor can be versatile and highly dependent on both the cell context and the chemical nature of the extracellular signaling messenger.


Received for publication May 20, 2008.

Accepted for publication December 1, 2008.

Address correspondence to: Dr Alain Rabié, Institut de Génomique Fonctionnelle, 141 rue de la Cardonille, 34094 Montpellier Cedex 5, France. E-mail: alain.rabie{at}igf.cnrs.fr







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics